The Journal of Immunology, Vol 157, Issue 10 4537-4545, Copyright © 1996 by American Association of Immunologists

ARTICLES

The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci

V Leclercq, M Lebastard, Y Belkaid, J Louis and G Milon
Unit of Cellular Immunophysiology, Pasteur Institute, Paris, France.

Human visceral leishmaniasis is mainly due to intracellular protozoan parasites of the Leishmania donovani complex, i.e., L. donovani and L. infantum (or L. chagasi). A mouse model has been established to monitor 1) the parasitic process initiated by L. infantum in three tissues they invade, and 2) parameters of the acquired immune response they trigger. Mice congenic at the Lsh locus and mice of inbred strains differing at the MHC locus have been inoculated by the i.v. route with L. infantum. The parasitic process has been evaluated by the follow-up of the parasitic load in the liver, the spleen, and, for the first time, in the bone marrow using a very sensitive limiting dilution assay. As previously established for L. donovani, the early outcome of L. infantum is also under the control of the Lsh locus in the liver; genes of the MHC complex are involved in the development of the subsequent acquired immune response. "Cure" or "noncure" haplotypes are the same for the two species of Leishmania; as far as the cure haplotype is concerned, whatever the tissues being screened, the parasites are never totally cleared, although the liver is the tissue in which the best parasite load reduction is achieved. Through immunostaining, it was established that sialoadhesin-positive stromal bone marrow macrophages contain parasites; such long-lived mononuclear phagocytes could be the host cells where the parasite can find "safe targets" unreactive to the dominant effector immune mechanism triggered by the replicative stage of the parasites.

This article has been cited by other articles:

				U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs J. Exp. Med., April 16, 2007; 204(4): 893 - 906. [Abstract] [Full Text] [PDF]

				J. K. White, P. Mastroeni, J.-F. Popoff, C. A. W. Evans, and J. M. Blackwell Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity J. Leukoc. Biol., March 1, 2005; 77(3): 311 - 320. [Abstract] [Full Text] [PDF]

				T. Lang, N. Courret, J.-H. Colle, G. Milon, and J.-C. Antoine The Levels and Patterns of Cytokines Produced by CD4 T Lymphocytes of BALB/c Mice Infected with Leishmania major by Inoculation into the Ear Dermis Depend on the Infectiousness and Size of the Inoculum Infect. Immun., May 1, 2003; 71(5): 2674 - 2683. [Abstract] [Full Text] [PDF]

				S. Ahmed, M. Colmenares, L. Soong, K. Goldsmith-Pestana, L. Munstermann, R. Molina, and D. McMahon-Pratt Intradermal Infection Model for Pathogenesis and Vaccine Studies of Murine Visceral Leishmaniasis Infect. Immun., January 1, 2003; 71(1): 401 - 410. [Abstract] [Full Text] [PDF]

				L. Altet, O. Francino, L. Solano-Gallego, C. Renier, and A. Sanchez Mapping and Sequencing of the Canine NRAMP1 Gene and Identification of Mutations in Leishmaniasis-Susceptible Dogs Infect. Immun., June 1, 2002; 70(6): 2763 - 2771. [Abstract] [Full Text] [PDF]

				E. Handman Leishmaniasis: Current Status of Vaccine Development Clin. Microbiol. Rev., April 1, 2001; 14(2): 229 - 243. [Abstract] [Full Text] [PDF]

				L. Nicolas, S. Sidjanski, J.-H. Colle, and G. Milon Leishmania major Reaches Distant Cutaneous Sites Where It Persists Transiently while Persisting Durably in the Primary Dermal Site and Its Draining Lymph Node: a Study with Laboratory Mice Infect. Immun., December 1, 2000; 68(12): 6561 - 6566. [Abstract] [Full Text] [PDF]

				S. E. J. Cotterell, C. R. Engwerda, and P. M. Kaye Enhanced Hematopoietic Activity Accompanies Parasite Expansion in the Spleen and Bone Marrow of Mice Infected with Leishmania donovani Infect. Immun., April 1, 2000; 68(4): 1840 - 1848. [Abstract] [Full Text] [PDF]

				S. E. J. Cotterell, C. R. Engwerda, and P. M. Kaye Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha Blood, March 1, 2000; 95(5): 1642 - 1651. [Abstract] [Full Text] [PDF]